Publications

doxorubicin (11 POSTS)

1989 (1 POST)

Effects of chronic administration of doxorubicin on myocardial creatine phosphokinase and antioxidant defenses and levels of lipid peroxidation in tissues and plasma of rats

Robison TW, Giri SN, Wilson DW. 1989. Effects of chronic administration of doxorubicin on myocardial creatine phosphokinase and antioxidant defenses and levels of lipid peroxidation in tissues and plasma of rats. J Biochem Toxicol 4(2):87-94; doi: 10.1002/jbt.2570040204.

View Abstract

1987 (3 POSTS)

Effects of chronic administration of doxorubicin on myocardial alpha-adrenergic receptors, histamine, cyclic nucleotides, calcium, norepinephrine, calmodulin, and guanylate cyclase activity, and plasma catecholamines in rats

Robison TW, Giri SN. 1987. Effects of chronic administration of doxorubicin on myocardial alpha-adrenergic receptors, histamine, cyclic nucleotides, calcium, norepinephrine, calmodulin, and guanylate cyclase activity, and plasma catecholamines in rats. Virchows Archiv B 54(3):182-189; doi: 10.1007/BF02899210.

View Abstract

Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, TxB2 and fatty acid in rats

Robison TW, Giri SN. 1987. Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, TxB2 and fatty acid in rats. Cancer Chemother Pharmacol 19(3):213-220; doi: 10.1007/BF00252975.

View Abstract

Effects of chronic administration of doxorubicin on heart phospholipase A2 activity and in vitro synthesis and degradation of prostaglandins in rats

Robison TW, Giri SN. 1987. Effects of chronic administration of doxorubicin on heart phospholipase A2 activity and in vitro synthesis and degradation of prostaglandins in rats. Prostaglandins Leukot Med 26(1):59-74; doi: 10.1016/0262-1746(87)90152-1.

View Abstract

1986 (3 POSTS)

Effects of chronic administration of doxorubicin on myocardial beta-adrenergic receptors

Robison TW, Giri SN. 1986. Effects of chronic administration of doxorubicin on myocardial beta-adrenergic receptors. Life Sci 39(8):731-736; doi: 10.1016/0024-3205(86)90021-4.

View Abstract

Effect of chronic administration of doxorubicin on myocardial antioxidant defenses and levels of lipid peroxidation in tissues and plasma

Robison TW, Giri SN. Effect of chronic administration of doxorubicin on myocardial antioxidant defenses and levels of lipid peroxidation in tissues and plasma. Federation of American Societies for Experimental Biology Annual Meeting, St. Louis, MO, 1986.

Effects of chronic administration of doxorubicin on heart adenylate cyclase activity in mice

Robison TW, Giri SN. 1986. Effects of chronic administration of doxorubicin on heart adenylate cyclase activity in mice. Biochem Biophys Res Commun 136(2):745-752; 10.1016/0006-291x(86)90502-4.

View Abstract

1985 (2 POSTS)

Effects of intravenous infusion of doxorubicin on blood chemistry, blood pressure, and heart rate in rabbits

Robison TW, Giri SN, Parker HR, Curry DL, Ishizaki G, Schiedt M. 1985. Effects of intravenous infusion of doxorubicin on blood chemistry, blood pressure, and heart rate in rabbits. J Appl Toxicol 5(6):382-387; doi: 10.1002/jat.2550050609.

View Abstract

Effect of chronic administration of doxorubicin on plasma levels of prostaglandins, and TxB2 in male Sprague Dawley rats

Robison TW, Giri SN. Effect of chronic administration of doxorubicin on plasma levels of prostaglandins, and TxB2 in male Sprague Dawley rats. Federation of American Societies for Experimental Biology Annual Meeting, Anaheim, CA, 1985.

1984 (2 POSTS)

Effects of intravenous infusion of doxorubicin on blood chemistry, blood pressure, and heart rate in rabbits

Robison TW, Giri SN, Parker HR, Curry DL, Ishizaki G, Schiedt M. Effects of intravenous infusion of doxorubicin on blood chemistry, blood pressure, and heart rate in rabbits. Federation of American Societies for Experimental Biology Annual Meeting, St. Louis, MO, 1984.

Effects of ibuprofen on doxorubicin toxicity in mice

Robison TW, Giri SN. 1984. Effects of ibuprofen on doxorubicin toxicity in mice. Pharmacol Res Commun 16(4):409-418; doi: 10.1016/s0031-6989(84)80008-9.

View Abstract